German establishments Ayoxxa Biosystems and Märzhäuser Wetzlar have introduced a new device for protein multiplex analysis.
Using the Ayoxxa Reader AR01, researchers will be able to analyse LUNARIS Multiplex assays.
Approved for routine laboratory work use in biomedical research, the device is said to offer the researchers a complete, flexible and user-friendly system for multiprotein analysis.
Ayoxxa Biosystems CEO Dr. Andreas Schmidt said: “With Märzhäuser, we are pleased to have found a development and manufacturing partner for the Ayoxxa Reader AR01 that has a solid international reputation based on high competence and quality standards.
“Our close collaboration has facilitated the quick and efficient development of a very important element of our technology platform.”
The instrument allows the fluorescence-based readout of a LUNARI Multiplex assay with up to 384 samples on a microtiter plate format in less than one hour, Ayoxxa said in a statement.
According to the company, Readout is fully automated using a self-developed control software which complements the already available analysis solution.
The latter application processes the acquired data for easy, streamlined biomarker quantification and detailed reporting.
LUNARIS is Ayoxxa's beads-on-a-chip technology platform to analyse picogram amounts of multiple biomarkers in biological samples.
Ayoxxa Biosystems commercialises a portfolio of ready-to-use biomarker detection kits, while Märzhäuser develops and manufactures manual and motor driven micro-positioning systems for microscopy appliances.
Image: Using Ayoxxa Reader AR01, researchers will be able to analyse LUNARIS Multiplex assays. Photo: © Steffen Maluche.
